How COVID unlocked the power of RNA vaccines
Elie Dolgin • January 12, 2021
The technology could revolutionize efforts to immunize against HIV, malaria, influenza and more.
The era of RNA vaccines has arrived — and dozens of companies are getting in the game.
Read more at Nature.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.